TrialBlood2017
Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL.
Wei Ding et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
250 papers cite itlatest 60 shown
this paperpooled ittrialcites it
TrialBlood2017
Wei Ding et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.